Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05078450
Other study ID # HUM00163570
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 22, 2021
Est. completion date February 1, 2023

Study information

Verified date December 2023
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mood Lifters is a revolutionary mental wellness program that teaches scientifically validated strategies in a supportive group setting. This study will test two new versions of the program designed specifically for graduate students and young professionals. Participants will need to attend 12 hour long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what the participants learn at home in order to improve their mood or mental wellness. Additionally, participants will complete a series of measures (approx. 1-1.5 hours) prior to, at the end of the program, 1 month after the program and 6 months after the program.


Recruitment information / eligibility

Status Completed
Enrollment 362
Est. completion date February 1, 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 32 Years
Eligibility Inclusion Criteria: - Participants ages 22-32 (must identify as either a graduate student or a young professional) Exclusion Criteria: - Active suicidality, mania, or psychosis

Study Design


Intervention

Behavioral:
Mood Lifters
Participants will need to attend 12 hour long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what they learn at home in order to improve their mood or mental wellness.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

References & Publications (2)

Garg T, Votta CM, Prakash N, Deldin PJ. An investigation into the effectiveness of Mood Lifters in the context of trauma exposure. Psychol Serv. 2023 Aug 24. doi: 10.1037/ser0000789. Online ahead of print. — View Citation

Prakash N, Votta CM, Deldin PJ. Treatment for graduate students: Blunting the emotional toll of postgraduate education. J Consult Clin Psychol. 2023 Dec;91(12):708-716. doi: 10.1037/ccp0000844. Epub 2023 Sep 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Health Questionnaire - 9 Assesses Depressive Symptoms (Range 0-27; higher scores indicate more significant symptoms of depression) through study completion, an average of 1 year
Primary Generalized Anxiety Disorder - 7 Assesses Anxiety Symptoms (Range 0-21; higher scores indicate more significant symptoms of anxiety) through study completion, an average of 1 year
Primary Perceived Stress Scale Assesses Perceived stress (Range 0-40; higher scores indicate more significant perceived stress) through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A